🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 19 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/04/2008 | 36,67 | 36,83 | 35,27 | 35,40 | -3,18% | 4,27% | 41.527.734 |
| 01/04/2008 | 36,63 | 37,08 | 36,31 | 36,56 | +0,98% | 2,11% | 43.345.804 |
| 31/03/2008 | 36,98 | 37,69 | 35,13 | 36,21 | -14,74% | 6,92% | 85.731.011 |
| 28/03/2008 | 42,71 | 43,64 | 42,35 | 42,47 | -0,60% | 3,02% | 11.887.778 |
| 27/03/2008 | 42,67 | 43,29 | 42,18 | 42,73 | +0,18% | 2,62% | 20.682.804 |
| 26/03/2008 | 42,49 | 42,98 | 42,18 | 42,65 | +0,07% | 1,89% | 21.383.497 |
| 25/03/2008 | 42,32 | 42,94 | 42,22 | 42,62 | +0,95% | 1,69% | 14.061.121 |
| 24/03/2008 | 41,62 | 42,73 | 41,28 | 42,22 | +2,05% | 3,48% | 18.329.520 |
| 20/03/2008 | 41,59 | 41,59 | 40,08 | 41,37 | +0,86% | 3,65% | 17.209.522 |
| 19/03/2008 | 41,33 | 41,98 | 40,94 | 41,02 | -0,46% | 2,52% | 16.114.782 |
| 18/03/2008 | 40,40 | 41,22 | 39,85 | 41,21 | +3,20% | 3,40% | 15.363.366 |
| 17/03/2008 | 38,65 | 40,13 | 38,28 | 39,93 | +2,15% | 4,79% | 15.763.073 |
| 14/03/2008 | 40,38 | 41,00 | 38,73 | 39,09 | -2,29% | 5,62% | 17.797.450 |
| 13/03/2008 | 40,36 | 40,75 | 39,64 | 40,01 | -1,23% | 2,77% | 21.246.418 |
| 12/03/2008 | 40,26 | 41,56 | 40,25 | 40,51 | +0,31% | 3,27% | 16.401.619 |
| 11/03/2008 | 39,39 | 40,44 | 39,22 | 40,38 | +2,57% | 3,10% | 17.351.002 |
| 10/03/2008 | 39,89 | 39,99 | 39,15 | 39,37 | -1,17% | 2,11% | 12.954.957 |
| 07/03/2008 | 40,13 | 41,03 | 39,62 | 39,84 | -1,51% | 3,52% | 16.117.402 |
| 06/03/2008 | 41,29 | 41,30 | 40,37 | 40,45 | -1,99% | 2,24% | 16.148.422 |
| 05/03/2008 | 41,76 | 41,87 | 40,76 | 41,27 | -1,17% | 2,65% | 18.069.930 |
| 04/03/2008 | 41,71 | 41,98 | 41,30 | 41,76 | -0,68% | 1,65% | 14.885.792 |
| 03/03/2008 | 42,64 | 42,64 | 41,84 | 42,04 | -0,54% | 1,88% | 12.245.775 |
| 29/02/2008 | 42,80 | 42,91 | 42,11 | 42,27 | -1,99% | 1,87% | 17.982.527 |
| 28/02/2008 | 43,34 | 43,50 | 42,78 | 43,13 | -0,53% | 1,67% | 10.876.354 |
| 27/02/2008 | 44,08 | 44,12 | 43,22 | 43,36 | -2,05% | 2,06% | 16.659.951 |
| 26/02/2008 | 44,42 | 44,74 | 44,06 | 44,27 | -0,85% | 1,55% | 10.225.860 |
| 25/02/2008 | 44,06 | 44,77 | 44,01 | 44,65 | +1,56% | 1,73% | 11.296.811 |
| 22/02/2008 | 44,11 | 44,35 | 43,28 | 43,96 | -0,13% | 2,42% | 13.047.286 |
| 21/02/2008 | 44,93 | 45,23 | 43,91 | 44,02 | -1,89% | 2,93% | 12.777.740 |
| 20/02/2008 | 44,68 | 44,90 | 44,06 | 44,87 | -0,11% | 1,88% | 14.091.827 |